Insulin therapy in childhood type 1 diabetes: Knowledge and practice in Senegal

A Sow1, D Boiro1, P S Sow1

  • 1Abass-Ndao Hospital Center, Cheikh Anta Diop Avenue, 25755 Dakar, Senegal.

Insights

Physician knowledge of insulin therapy for childhood type 1 diabetes (T1D) in Senegal was limited. Enhanced training is recommended to improve T1D management and patient outcomes.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Public Health

Background:

  • Childhood type 1 diabetes (T1D) significantly impacts children's quality of life.
  • Insulin therapy is crucial for managing blood glucose levels in T1D.
  • Assessing physician knowledge is vital for effective diabetes care.

Purpose of the Study:

  • To evaluate the knowledge level of physicians regarding insulin therapy for pediatric diabetes.
  • To identify potential gaps in diabetes management education among healthcare providers in Senegal.

Main Methods:

  • A multicenter survey conducted over five months in five university hospital centers in Dakar, Senegal.
  • Interviewed 82 physicians, including pediatricians and those specializing in pediatrics.
  • Collected data on insulin prescription practices and knowledge of T1D management.

Main Results:

  • 75.6% of physicians recommended fast-acting insulins; 50% recommended insulin mixtures.
  • 91% advised varying insulin injection sites.
  • 54.9% of physicians adjusted insulin doses for physical activity, with over half reducing doses.

Conclusions:

  • Physician knowledge of insulin therapy for pediatric diabetes in Senegal is limited.
  • There is a need to strengthen and monitor training programs for healthcare providers managing T1D.
  • Improved education can enhance the quality of care for children with diabetes.
Abstract

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
384
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.2K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.7K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
688
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
381
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
797